Challenges and Perspectives of Neurological Disorders.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

1. The role of AI-assisted drug repurposing in neurological disorders: a systematic review of validation strategies, challenges and opportunities.Journal of nanobiotechnology · 2026
   Pooled it
2. Neuronal intranuclear inclusion disease with stroke-mimicking onset: a case report and systematic review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
   Pooled it
3. Panax quinquefolius ginsenosides for neuroprotection in Parkinson's disease via TNF-α inhibition.Journal of natural medicines · 2026
   Article
4. Nanotechnology in Pediatric Neurology: Applications and Innovations.Pharmaceutics · 2026
   Review
5. Artificial intelligence-based biomarkers for the diagnosis and treatment of neurological conditions: a narrative review.Molecular brain · 2026
   Review
6. Feasibility of Immersive Virtual Reality for Delivering Semantic Feature Analysis to Adults with Communication Disorders and Normal Cognitive Aging.International journal of telerehabilitation · 2026
   Article
7. Early autism detection: a review of emerging technologies, biomarkers, and explainable AI approaches.Molecular brain · 2025
   Review
8. Challenges and Perspectives of Neurological Disorders: Series II.Brain sciences · 2025
   Article
9. Alleviation of Neurological Disorders by Targeting Neurodegenerative-Associated Enzymes: Natural and Synthetic Molecules.International journal of molecular sciences · 2025
   Review
10. Therapeutic Potential of Alpha-Lipoic Acid: Unraveling Its Role in Oxidative Stress and Inflammatory Conditions.Current issues in molecular biology · 2025
    Review
11. Siddha medicine and modern neuroscience: a synergistic approach to neurological care.3 Biotech · 2025
    Review
12. How can patients shape digital medicine? A rapid review of patient and public involvement and engagement in the development of digital health technologies for neurological conditions.Expert review of pharmacoeconomics & outcomes research · 2025
    Review
13. Viruses and the Brain-A Relationship Prone to Trouble.Viruses · 2025
    Review
14. Advances in chromosomal microarray analysis: Transforming neurology and neurosurgery.Brain & spine · 2025
    Review
15. Differential gene expression analysis supports dysregulation of mitochondrial activity as a new perspective for glioblastoma's aggressiveness.Heliyon · 2024
    Article
16. Explainable Machine Learning Models for Brain Diseases: Insights from a Systematic Review.Neurology international · 2024
    Review
17. A Comprehensive Review on Navigating the Neurological Landscape of COVID-19: Insights Into Etiopathogenesis and Clinical Management.Cureus · 2024
    Review
18. Integrating Genome Sequencing and Untargeted Metabolomics in Monozygotic Twins with a Rare Complex Neurological Disorder.Metabolites · 2024
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract